Table 2.
Virus name |
Production strategy |
Proteins expressed (promoter) |
Reference |
---|---|---|---|
Enveloped VLPs | |||
Parvovirus B19 | Co-expression using a bicistronic baculovirus | [VP1 (p10), VP2 (polh)] | Brown et al. (1991) |
Co-infection using two monocistronic baculoviruses | VP1 (polh), VP2 (polh) |
Bansal et al. (1993); Kajigaya et al. (1991); Tsao et al. (1996) Kajigaya et al. (1991) |
|
Blue tongue virus | Co-expression using a bicistronic baculovirus | [VP3 (polh), VP7 (polh)] | French and Roy (1990) |
Combined co-infection and co-expression with two baculoviruses | [VP2 (polh), VP5 (polh)], [VP3 (polh), VP7 (polh)] |
French et al. (1990) | |
Co-expression using quadruple-cistronic baculoviruses | [VP2 (polh), VP3 (p10), VP5 (polh) VP7 (p10)] | Belyaev and Roy (1993) | |
Chimeric BTV—epizootic hemorrhagic disease virus particles | Co-infection using two monocistronic baculoviruses | EHDV VP3 (polh), BTV VP7 (polh) | Le Blois et al. (1991) |
Co-infection using two monocistronic baculoviruses and one bicistronic baculovirus | EHDV VP3 (polh), BTV VP7 (polh), [BTV VP2 (polh), BTV VP5 (polh)] |
Le Blois et al. (1991) | |
Rotavirus | Co-infection using two monicistronic baculoviruses | VP2 (polh), VP6 (polh) | Labbe et al. (1991) |
Co-infection using three monocistronic baculoviruses | VP2 (polh), VP4 (polh), VP6 (polh) | Conner et al. (1996); Crawford et al. (1994); O'Neal et al. (1997) | |
Co-infection using three monocistronic baculoviruses | VP2 (polh), VP6 (polh), VP7 (polh) | Conner et al. (1996); Crawford et al. (1994); O'Neal et al. (1997) | |
Co-infection using four monocistronic baculoviruses | VP2 (polh), VP4 (polh), VP6 (polh), VP7 (polh) | Conner et al. (1996); Crawford et al. (1994); O'Neal et al. (1997) | |
Poliovirus | Co-expression from a single baculovirus with poliovirus coding region | VP0, VP1, VP3 (polh) | Urakawa et al. (1989) |
Co-infection using three monocistronic baculovirus | VP0 (polh), VP1(polh), VP3 (polh) | Brautigam et al. (1993) | |
Co-infection using one monocistronic baculovirus and one bicistronic baculovirus | [VP0 (polh), VP3 (p10)], VP1 (polh) | Brautigam et al. (1993) | |
Enterovirus 71 | Co-infection using two monocistronic baculoviruses | P1 (polh), CD3 (p10) *note: VP0, VP1, VP3 were produced from the polyprotein (P1 gene product) through CD3 mediated-cleavage |
Chung et al. (2006); Hu et al. (2003) |
Co-expression using a bicistronic baculovirus | [P1 (polh), CD3 (p10)] *note: VP0, VP1, VP3 were produced from the polyprotein (P1 gene product) through CD3 mediated-cleavage |
Chung et al. (2006); Hu et al. (2003) | |
Human papillomavirus (HPV) | Co-expression using one bicistronic baculovirus | [L1 (polh), L2 (pSyn)] | Kirnbauer et al. (1993) |
Co-infection using two monocistronic baculoviruses | L1 (polh), L2 (p10) | Volpers et al. (1994) | |
Herpes simplex virus (HSV) | Co-infection using up to six monocistronic baculoviruses | VP23 (polh), VP5 (polh), VP21 & VP24 (polh), VP22a (polh), VP26 (polh), and VP19C (polh) | Tatman et al. (1994); Thomsen et al. (1994) |
Marek's disease virus (MDV) | Co-infection using up to six monocistronic baculoviruses | MDV homologues of HSV proteins VP23 (polh), VP5 (polh), VP24–VP21 (polh), VP22a (polh), VP26 (polh), and VP19C (polh) | Kut and Rasschaert (2004) |
Simian virus 40 (SV40) | Co-infection using three monocistronic viruses | VP1 (polh), VP2 (polh), VP3 (polh) | Inoue et al. (2008); Kosukegawa et al. (1996) |
Adeno associated virus (AAV) | Co-infection using two monocistronic viruses | VP2 (polh), VP3 (polh) | Hoque et al. (1999) |
Enveloped VLPs | |||
Influenza | Co-expression using a quadruple recombinant baculovirus | [HA (polh), NA (p10), M1 (polh) and M2 (p10)] | Latham and Galarza (2001) |
Co-expression using a tricistronic baculovirus | [HA (polh), NA (polh), M1 (polh)] | Bright et al. (2007); Pushko et al., 2005, Pushko et al., 2007 | |
Co-infection using one monocistronic and one bicistronic baculovirus | [HA (polh), NA (p10)], M1 (polh) | Wen et al. (2009) | |
Co-infection using two monocistronic baculoviruses | HA (Pcap/polh), M1 (Pcap/polh) | Quan et al. (2007) | |
Co-infection using three monocistronic baculoviruses | H5N1 HA (polh), NA (polh), M1 (polh) | Kang et al. (2009) | |
Simian immunodeficiency virus (SIV) | Co-infection using two monocistronic baculoviruses | Gag (polh), Env (Pcap/polh) gene products | Kang and Compans (2003); Yamshchikov et al. (1995) |
Human immunodeficiency virus (HIV) | Co-infection using two monocistronic baculoviruses | Gag (polh) and protease (polh) gene products | Overton et al. (1989) |
Co-infection using two monocistronic baculoviruses | Gag (polh), Env (polh) gene products | Deml et al. (1997); Wang et al. (2007) | |
Co-expression using a bicistronic baculovirus | [Gag (polh), Env (p10) gene products] | Buonaguro et al., 2001, Buonaguro et al., 2006; Cruz et al. (2000) | |
Co-infection using two monocistronic baculoviruses | Gag (Pcap/polh), Env (Pcap/polh) gene products | Sailaja et al. (2007) | |
Feline leukaemia virus (FeLV) | Co-infection using two monocistronic baculoviruses | Gag (polh), gp85 (polh) | Thomsen et al. (1992) |
Hepatitis B virus (HBV) | Co-expression using a bicistronic baculovirus | [Core antigen (polh) and surface antigen (polh)] | Takehara et al. (1988). |
SARS coronavirus | Co-infection using three monocistronic baculoviruses | Spike (polh), envelope (polh) and membrane (polh) proteins | Ho et al. (2004); Mortola and Roy (2004) |
Co-expression using a tricistronic baculovirus | [Spike (polh), envelope (polh) and membrane (polh) proteins] | Mortola and Roy (2004) | |
Ebolavirus | Co-infection using two monocistronic baculoviruses | VP40 (Pcap/polh), GP (Pcap/polh) | Sun et al. (2009); Ye et al. (2006) |
Hantaan virus | Co-infection using two monocistronic baculoviruses | Nucleocapsid protein (polh), [glycoproteins G1 and G2 (polh)] | Betenbaugh et al. (1995) |
[] refers to those proteins produced from a single virus.
polh: polyhedrin promoter.
p10: p10 promoter.
Pcap/polh: hybrid capsid/polyhedrin promoter.